ASAN FOUNDATION

ASAN FOUNDATION logo
πŸ‡°πŸ‡·South Korea
Ownership
Private
Established
1989-06-23
Employees
501
Market Cap
-
Website
https://ails.amc.seoul.kr

AVIAR(MX-02) Robotic-assisted Percutaneous Coronary Intervention

First Posted Date
2023-08-08
Last Posted Date
2024-07-17
Lead Sponsor
Asan Medical Center
Target Recruit Count
21
Registration Number
NCT05981859
Locations
πŸ‡°πŸ‡·

The Catholic University of Korea Eunpyeong St. Mary's Hospital, Seoul, Korea, Republic of

πŸ‡°πŸ‡·

Asan Medical Center, Seoul, Korea, Republic of

Textbook and Survival Outcomes of MIPD in South Korea

Completed
Conditions
First Posted Date
2023-08-04
Last Posted Date
2023-08-04
Lead Sponsor
Asan Medical Center
Target Recruit Count
1552
Registration Number
NCT05975710
Locations
πŸ‡°πŸ‡·

Asan medical center, Seoul, Korea, Republic of

Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in Invasive Lobular Carcinoma

Phase 2
Completed
Conditions
Interventions
First Posted Date
2023-07-25
Last Posted Date
2024-08-21
Lead Sponsor
Asan Medical Center
Target Recruit Count
23
Registration Number
NCT05960201
Locations
πŸ‡°πŸ‡·

Asan Medical Center, Seoul, Korea, Republic of

F-18 FDOPA PET/CT Versus I-123 MIBG Scintigraphy With SPECT/CT for the Diagnosis of Pheochromocytoma and Paraganglioma

First Posted Date
2023-07-17
Last Posted Date
2023-07-17
Lead Sponsor
Asan Medical Center
Target Recruit Count
32
Registration Number
NCT05948137
Locations
πŸ‡°πŸ‡·

Asan Medical Center, Seoul, Songpa-gu, Korea, Republic of

Development and Management of Registry in Patients With Gynecologic Cancer in Korea

First Posted Date
2023-06-22
Last Posted Date
2023-06-22
Lead Sponsor
Asan Medical Center
Target Recruit Count
13500
Registration Number
NCT05912972
Locations
πŸ‡°πŸ‡·

Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea, Republic of

A Phase II Stydy of Bevacizumab Plus Erlotinib in Patients for Krebs Cycle Altered Cancer

First Posted Date
2023-06-15
Last Posted Date
2023-06-15
Lead Sponsor
Asan Medical Center
Target Recruit Count
32
Registration Number
NCT05904457
Locations
πŸ‡°πŸ‡·

Cha University Bundang Medical Center, Seongnam, Gyeonggi-do, Korea, Republic of

πŸ‡°πŸ‡·

Chungnam National University Hospital, Daejeon, Chungcheongnam-do, Korea, Republic of

πŸ‡°πŸ‡·

Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea, Republic of

and more 7 locations

Rivoceranib Plus Paclitaxel in Patients With Gastrointestinal Stromal Tumor

First Posted Date
2023-06-15
Last Posted Date
2024-02-28
Lead Sponsor
Asan Medical Center
Target Recruit Count
48
Registration Number
NCT05905887
Locations
πŸ‡°πŸ‡·

Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of

Clinical Outcomes of Surgery After Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer

First Posted Date
2023-06-05
Last Posted Date
2023-06-05
Lead Sponsor
Asan Medical Center
Target Recruit Count
1
Registration Number
NCT05888129
Locations
πŸ‡°πŸ‡·

Asan medical center, Seoul, Korea, Republic of

Clinical Impact of Intravascular Ultrasound-Based Artificial Intelligence Technologies (INNOVATE-PCI)

Recruiting
Conditions
First Posted Date
2023-04-11
Last Posted Date
2024-08-02
Lead Sponsor
Asan Medical Center
Target Recruit Count
3000
Registration Number
NCT05807841
Locations
πŸ‡°πŸ‡·

Soon Chun Hyang University Hospital Bucheon, Bucheon, Korea, Republic of

πŸ‡°πŸ‡·

Inje University Pusan Paik Hospital, Busan, Korea, Republic of

πŸ‡°πŸ‡·

The Catholic university of korea, daejeon st. mary's hospital, Daejeon, Korea, Republic of

and more 13 locations
Β© Copyright 2024. All Rights Reserved by MedPath